Shaista Asif is the Group Chief Operating Officer at Pure Health, the largest integrated healthcare company in the UAE. Overseeing the Group’s diversified portfolio, including hospitals, clinics, laboratories, health insurance, healthcare procurement, and health tech solutions, Shaista is at the forefront in changing the way healthcare is delivered in the country. She has spearheaded the largest number of healthcare acquisitions in the UAE over the last three years, making Pure Health the fastest-growing healthcare company in the region. With a strong track record in delivering transformational change, Shaista has led Pure Health’s consolidation, spearheading the execution of the Group’s strategy, quality distinction, growth, and development in the healthcare segment in the UAE since 2010. With over 17 years in senior leadership positions in the healthcare and technology domain, Shaista brings a wealth of experience in strategic planning and is recognised for her in-depth analytical ability to facilitate operational and procedural planning to focus on the Group’s growth and optimisation. Moving from sick care to preventive care, Shaista’s North Star is Longevity. Pure Health is working towards creating the ‘Healthcare in the Cloud’ as its enabler, where the company is focused on embracing the 4th Industrial Revolution. Shaista believes in Technological Singularity, and how the increase in compute power is bringing it closer. Pure Health is working towards creating a healthcare ecosystem where people don’t fall sick, but instead live healthier and fuller lives, for longer!

Chief at Forbes Middle East & CEO of Arab Publisher House. She leads a team of creative expertise and capabilities that produce distinguished lists, rankings, reports, and stories celebrating the region. She has studied media at Yarmouk University in Jordan and began her career in media at Jordan Radio and Television Corporation. She worked there as a news editor and then moved to CNBC Arabia as a Senior Producer. In 2010, she established Arab Publisher House, after obtaining a license from Forbes Media Magazine to publish the magazine and website in both Arabic and English.

Her Excellency Dr. Noura Al Ghaithi is the Undersecretary of the Department of Health – Abu Dhabi (DoH), where she plays a strategic role in the development of the Emirate’s healthcare sector through overseeing its strategy and continuously developing priority areas outlining future goals. Dr. Al Ghaithi’s role is focused on ensuring the Department’s ongoing alignment with the Emirate’s strategic direction towards the continuous improvement of the healthcare system in accordance with international standards and best practices. In addition to enabling research and innovation in life sciences, employing the latest revolutionary breakthroughs such as Artificial Intelligence (AI) and big data in healthcare as well as leading initiatives and programmes focused on developing workforce capabilities and Emiratision. Furthermore, HE oversees the development of the Emirate’s various models of care to purposefully enhance the efficiency and quality of healthcare services across Abu Dhabi. Dr. Al Ghaithi firmly believes in the importance of applying technology to improve patient care and ensure access for all community members. HE has consistently demonstrated exceptional leadership skills in managing change and introducing new practices that deliver measurable outcomes. She has accumulated exceptional skills in driving strategic planning, hospital administration, medical affairs and the delivery of world-class healthcare services.

Her Excellency Mubaraka Ibrahim the acting CIO Emirates health services and a passionate technology enthusiast, has spearheaded the Digital Transformation Journey. She played a crucial role in the Riayati “Electronic Unified Medical Record” committee for securing pharmaceutical supply chains that uphold post-pandemic resiliency. As a seasoned health care IT leader with over 30 years' experience, she has a proven track record of leading government entities through complex changes, implementing innovative solutions, and improving patient care. Since her appointment as Acting CIO at EHS, Mubaraka has emerged as an architect in achieving impeccable achievements in sustainability goals aligned with the UAE's NET ZERO initiative. Mubaraka is an ardent advocate for emerging technologies to improve healthcare. She offered a pragmatic approach towards Implementing digital health technology, optimizing healthcare facility operations, reevaluating care pathways, and investing in advanced data analytics. Among the first members of HIMSS in the region, she achieved the HealthCare IT Leader Hall of Fame Award (HIMSS Middle East). Being a distinguished graduate of the UAE Government Leaders Program, she is currently a highly anticipated member of the UAE Government's Next 50. By setting the tone for other women and professionals in the region to follow, she is an inspiring leader blazing a trail for others to follow. She is the first leader in the region to achieve exponential conversion rates of physical patient visits to virtual resulting a phenomenal reduction of 15 Million Tonnes of CO2 emission. In its pursuit of addressing and adhering to sustainability in UAE health care, Mubaraka has proven to be an invaluable asset to the industry and has taken a leading role in utilizing technology to improve the quality of patient care.

Dr. Amin Al Ameeri is a distinguished healthcare leader with a proven track record of innovation and excellence. As the Assistant Undersecretary at the Ministry of Health and Prevention in the United Arab Emirates, H.E. oversees critical functions such as setting standards, drug administration, licensing, inspection, and organ donation and transplantation. With a Ph.D. in Blood Transfusion Medicine from the University of Aberdeen in Scotland, Dr. Al Ameeri has made significant contributions to the field. His expertise and dedication have been recognized with numerous awards, both locally and internationally. A visionary leader, Dr. Al Ameeri is committed to improving healthcare quality and accessibility in the UAE. His strategic guidance and innovative approaches have played a pivotal role in advancing the nation's healthcare system.

Dr. Asma Al-Mannaei is an accomplished executive director of research and innovation in the Department of Health Abu Dhabi, with over 18 years of experience in Public Health, Strategy & Policy, Quality and Healthcare Research and Innovation. With an extensive background in healthcare Management, she is an expert in leading the transformation of healthcare life science in Abu Dhabi. Dr. Al-Mannaei is recognized for her innovative strategies and her ability to drive success in complex projects. She holds an MBBS from UAEU, a Master of Public Health from Johns Hopkins and Executive Education of Advanced Leadership and Management from Harvard Kennedy school.

Saeed Jaber Al Kuwaiti holds the esteemed position of Group Chief Executive Officer at SEHA, overseeing the strategic direction and operational execution of UAE's leading healthcare network. In his pivotal role, Saeed is instrumental in driving financial growth and performance while maintaining a steadfast commitment to delivering outstanding patient-centric care in collaboration with Pure Health Group. His leadership ensures SEHA's reputation as a top-tier healthcare provider, continually advancing clinical excellence, pioneering in medical innovations, and elevating patient experience. Having been part of the SEHA network since its inception in 2007, Al Kuwaiti has had notable roles across the organization, including Chief Financial Officer at Tawam Hospital, Chief Executive Officer at both Mafraq Hospital and Tawam Hospital and Regional CEO for Al Ain Region (Tawam, Al Ain and Al Wagan Hospital). With over 24 years of experience, Saeed is a seasoned healthcare leader with significant achievements across healthcare and financial management. This includes playing a significant part in enhancing the overall position of Tawam Hospital as a provider for comprehensive oncology services in the country, Sheikh Khalifa Medical City as a Center of Excellence in Pediatric Cardiac Surgery, Corniche Hospital as a leading feto-maternal service provider, SEHA Kidney Care as the largest dialysis provider and Sakina as the 1st dedicated mental health service provider in the region, as well as chairing the first insurance and billing committee for implementation of health insurance in Abu Dhabi, which heralded the successful introduction of mandatory health insurance. He also led the successful activation of Sheikh Shakhbout Medical City (SSMC) and Sheikh Tahnoon Medical City (STMC) Al Kuwaiti has a bachelor’s degree in Management Information Systems from the University of Arizona USA, in addition to a Master of Business Administration from Griffith University, Australia.

Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity. Dmitry is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy, and philanthropy. He leads the activities of the consortium’s investment arms - Deep Knowledge Ventures, focused on DeepTech and advanced science projects, and Longevity. Capital, which prioritizes the convergence of Longevity and Artificial Intelligence. In addition to his business experience, Dmitry is involved in several scientific endeavours. He has a major interest in anti-aging and healthy longevity, which is reflected in the full scope of his personal and professional activities. Dmitry is the author of the books ‘Biomarkers of Human Longevity’ and ‘Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History’.

Neil Warma has been a successful healthcare entrepreneur for over 25 years having managed and advised numerous biotechnology and pharmaceutical companies across the globe. He is the president, CEO, and board director of Mongoose Bio, a company recently spun out of the MD Anderson Cancer Center, and he focuses on transforming the treatment of both rare and common cancers with its unique cellular therapy technology. Additionally, Neil is the CEO and Board Director of ProMIS Neurosciences (Nasdaq:PMN), a publicly traded, clinical-stage company developing novel treatments for multiple neurodegenerative diseases including Alzheimer’s Disease, ALS, and Parkinson’s, based on revolutionary technology targeting misfolded proteins. Neil currently serves on the Board of Directors of the Biotechnology Innovation Organization (BIO), GenrAb Inc. and Ridgeline Therapeutics. Mr. Warma obtained an honors Bachelor of Science degree specializing in neuroscience from the University of Toronto and an International MBA from the Schulich School of Business at York University in Toronto.

Alex Aliper, PhD, is the President of Insilico Medicine. He pioneered the application of AI in multi-omics data for drug discovery and drug repurposing, generative chemistry, and generative biology and put an AI-designed drug into human clinical trials. Alex built a team of over 100 AI engineers who developed state-of-the-art software products for target discovery, small molecule generation, and clinical trial outcome prediction.

Clinician and full professor at the Shanghai University of Medicine and Health. Full time chief associate oncologist at Shanghai Renji University Hospital of Jiaotong. Founding Vice-President of Healthy Longevity Medicine Society. Training at Harvard Medical School affiliated hospitals (Mass General. Beth Israel, Brigham's and Dana Farber), Columbia University Presbyterian Hospital and Basel University Hospital. Specialist in Internal Medicine and Medical Oncology. Research focus on healthy longevity medicine, Artificial Intelligence (AI) and digital health with a research focus on oncology, preventative and precision medicine, biogerontology and geroncology. Prof. Bischof spent a decade practicing medicine, lecturing at medical schools and performing clinic and translational research in New York, Shanghai and Basel, Switzerland. She has extensive experience in scientific research and clinical practice at the following well known and highly reputable institutions: Fudan Cancer Institute and Hospital, Shanghai; Zhongshan Hospital (Fudan University). Renji Hospital (Jiaotong University) and Shanghai East Hospital (Tongji University).

Dr Jack Bartram is a Consultant Paediatric Haematologist, and the Clinical Director of the Malignancy Diagnostic Service at Great Ormond Street Hospital for Children (GOSH), London, UK. He undertook a PhD at UCL Institute of Child Health, then a leukaemia research fellowship in the Genomic Medicine Programme at The Hospital for Sick Children “SickKids” in Toronto. Dr Bartram leads on molecular diagnostics and has extensive expertise in high throughput sequencing in cancer. His research interest involves using advanced molecular diagnostic techniques to predict outcomes and find targets for novel therapies for children with haematological malignancies, as well as the application of AI to these datasets. Dr Bartram is co-principal investigator on two studies looking at integration of multimodal data in cancer: REVEALL (RElapse-specific therapeutic Vulnerability Evaluation in childhood & young adult Acute Lymphoblastic Leukaemia) study and the SAIL (Scientific Advances in Infant Leukaemia) study. He is currently the Clinical Lead for Haematological Malignancy Genomics in the NHS England North London Genomic Laboratory Hub and has been responsible for the implementation of advanced genomics and whole genome sequencing into clinical practice at GOSH.

Dimitri is a global leader with extensive pharmaceutical industry background, and more than 25 years of international work experience in the US, Europe, Japan, and the Middle East. Recognized as an innovative and organizational change leader who understands market dynamics and the importance of building effective win-win working relationships, Dimitri makes bold bets on the future. As Chief Executive Officer of Saudi Chemical Pharma, Dimitri has full oversight and accountability for the strategy and performance of the 4 legal entities under the Pharma sector umbrella: SITCO, AJA Pharma, CCCI and CSC. Prior to joining Saudi Chemical in September ’23, Dimitri spend 15 years with Eli Lilly & Company in a variety of roles around the world. Eli Lilly and Company is an American pharmaceutical company with over 33,000 employees, and is the largest pharmaceutical company in the world by market capitalization. As President & General Manager of Eli Lilly Saudi Arabia Ltd, Dimitri had full accountability for delivering the regional enterprise growth and transformation agenda across Diabetes, Immunology, Oncology, and Pain Therapeutic Areas. In 2021, Eli Lilly became the first pharmaceutical company to obtain the Regional Headquarter (RHQ) license, placing Riyadh at the center of healthcare in the region. Prior to relocating to Saudi Arabia in 2018, Dimitri was accountable for Strategy & Operations of Lilly USA Diabetes, the single largest Eli Lilly business entity, with revenue in excess of $5Bn. Before his transfer to Eli Lilly USA, Dimitri spend 8 years with Lilly in Japan, where he led the introduction and acceleration of new and existing innovative brands, as well as the digital transformation of the 2nd largest Lilly affiliate. A dual Greek-Belgian citizen and a graduate from NU in Michigan (USA), Dimitri calls Riyadh home, is fully integrated into Saudi society, and is committed to the long-term success of the Kingdom.

Hayat Biotech's Senior Advisor and Head of Research and Development, Dr. Nawal Al Kaabi is a highly accomplished infectious diseases consultant and an esteemed figure in the field. She has been the Chair of the SEHA Infectious Diseases and Infection Control Council since 2012 and previously served as Chief Medical Officer at Sheikh Khalifa Medical City. In recognition of her invaluable contributions to public health, she was appointed as the Chair of the National Covid-19 Clinical Committee in February 2020. Dr. Al Kaabi is also a renowned pediatric consultant who has made significant contributions to her field. An accomplished researcher, Dr. Al Kaabi has published numerous papers and has presented her findings at several international conferences, as well as serves as the Principal Investigator of multiple clinical trials. Furthermore, Dr. Nawal is a member of the WHO Guideline Development Group for Monkeypox and was part of the experts that developed WHO guiding principles for pathogen genome data sharing. An accomplished researcher, Dr. Al Kaabi has published numerous papers and has presented her findings at several international conferences. She serves as the Principal Investigator of multiple clinical trials, including the randomized, double-blind, parallel placebo-controlled, phase III clinical trial to evaluate the safety and efficacy of inactivated SARS-CoV-2 vaccines in the healthy population aged 18 years old and above.

A lifetime dedicated to excellence in the eye healthcare field within the MENA region. Mutasim Alireza, primary role, is CEO & Board member of Magrabi Hospitals & Centers, the largest eye care network in MENA region, providing eye care to more than 2,000,000 patients & performing more than 200,000 sight preserving surgeries annually. During his 27 year tenure as CEO & partner, Mutasim has led the massive expansion of Magrabi hospitals & Centers (34 hospitals & Centers across the region) while achieving top scores in local & international quality accreditation along with integrating Dentistry & other services within this unmatched healthcare platform across the MENA region. Currently, Mutasim’s prime focus, apart from continuing the growth of the company, is on digitization development and patient experience. These are two major corner stones within the company’s mission. Mutasim is also chairman of the board of AMI Saudi Arabia LTD, a leading hospital operation & management company in KSA that amongst other state-owned hospitals previously managed, on a turn key basis for 18 years, the King Khaled Eye specialist Hospital (KKESH) in Riyadh. He is also a board member of Imdad, a leading company of aesthetic medicine in the Middle East. Mutasim served on the Makkah region Healthcare Committee under the auspices of the region’s governor. This committee started the journey of healthcare accreditation in KSA & inspired other countries in the region to follow suit. He also previously served as the president Health Services Committee at the Jeddah Chamber of Commerce and continues till today to be a member of the National Healthcare Committee of the Saudi Chambers of Commerce. Mutasim was one of the founders of Ebsar Charity Organization for rehabilitating those with vision impairment to be self-dependent & productive elements of society. Mutasim also ventured into the education sector, and along with his wife they founded NUN Academy, a bilingual secondary school in Jeddah in partnership with Kunskapsskolan of Sweden with the mission of preparing students for a meaningful productive life; rooted locally yet connected globally. Mutasim is a passionate cyclist, himself along with his wife & children have participated in many triathlons as well as ironman races locally& internationally. In the Jeddah races, when not racing, Mutasim enjoys volunteering to support the growth of the triathlon sport within the community.

Cheikh-Lahlou joined Cooper Pharma in 2000 and has served as CEO since 2003. The company has nine distribution centers and ten manufacturing sites across Morocco, Rwanda, the Ivory Coast, Spain, the Czech Republic, and Saudi Arabia. It has manufacturing alliances with Merck, Pfizer, GSK, Abbott and Cipla among others. Cooper Pharma owns two pharma companies in Europe— one in Spain, and one in the Czech Republic. It has had a joint venture in manufacturing with Spimaco-Dammam Pharma in Saudi Arabia since 2013. Cheikh-Lahlou is also the vice president of the Moroccan Federation of Pharmaceuticals Industry and Innovation (FMIIP).

Beshara became CEO of the Mohamed & Obaid Almulla Group in 2018, having joined the group in 2017 as Group General Counsel. The group’s portfolio covers healthcare, travel and tourism, hospitality, and real estate. Beshara is also the CEO of American Hospital Dubai, the group's flagship brand. In 2021, the American Hospital Dubai announced a collaboration with Siemens Healthineers for enhanced diagnostic imaging and core diagnostics capabilities. In the same year, the American Health Academic Institute was launched as the education arm of American Hospital.

Vincenzo Ventricelli, Chief Executive Officer of Philips Middle East, Türkiye and Africa (META), started his tenure at Philips 25 years ago in Italy. Drawing from his deep multi-regional experience across the Personal Health (consumer) and Health Systems (health tech) business, Ventricelli helps to create solutions that make a meaningful difference to the healthcare community. Ventricelli is inspired by Philips’ goal of improving 2.5 billion lives per year by 2030, which drives him to continue to realize growth across META with fit for purpose teams and solutions that hold Philips’ customers and partners at its core. Vincenzo Ventricelli was appointed as Chief Executive Officer of Philips Middle East and Türkiye in 2020, which was expanded to include Africa from January 2021, as lead for the full META region. As a passionate business leader, with a proven track record, Ventricelli focuses on realizing the region’s strategic objectives to drive growth for Philips META. He also plays an active role in helping the brand create meaningful solutions for its customers and partners, in support of Philips’ global ambition of improving 2.5 billion lives per year by 2030. Ventricelli joined Philips in Italy, 25 years ago, where he took on various sales and marketing responsibilities; each priming him for his role as Marketing Director for Central & Eastern Europe ten years later, from 2006. From here, Ventricelli focused his energy on the Philips Consumer Lifestyle business based out of Dubai. First as Marketing Director for Philips Consumer Lifestyle, Middle East & Africa (2008), which catapulted him into the sales department as Senior Sales Director for Philips Personal Health Middle East and Türkiye (2011), before he became Market Leader for Philips Personal Health for Middle East and Türkiye (2015). His role included driving Philips’ Personal Health Strategy, which saw increased brand preference in the region, which in turn secured double digit business growth. In 2018, Ventricelli was appointed as Health Systems Market Leader at Philips Middle East and Türkiye. In this role, he built a strong team and accelerated Philips’ Health Systems transformation into a solutions business. Ventricelli holds a bachelor’s degree in business administration from the Bocconi University of Milan. He has three children, and lives in Dubai where he enjoys reading, or playing tennis and beach sports.

Akbar Moideen is a man brimming with self-belief to follow his own dreams. He is the Vice-President of the Healthcare Division of the well-known Thumbay Group. Highly encouraged by H.H. Sheikh Mohammed Bin Rashid Al Maktoum’s inspirational leadership and pearls of wisdom, Akbar has been instrumental in shaping its strategic vision. With a long history of successful business ventures and a distinguished line of accomplished ancestors, including his father, Dr. Thumbay Moideen (founder president of Thumbay Group), Akbar finds motivation in his family’s business acumen and has become a key figure in the healthcare industry. Akbar emphasizes their commitment to the latest healthcare technologies, aiming for HIMSS Stage 7 certification, where paper becomes obsolete, and AI and digital integration take the forefront. A staunch believer in the intrinsic value of healthcare to the community, he underscores its significance in the UAE. One of his key initiatives has been to promote Thumbay Hospitals in the medical tourism segment aggressively, with Thumbay pioneering inbound medical tourism in the UAE since 2007. The Group’s ultra-modern healthcare services are promoted to international patients across 87 countries through tie-ups with representative offices. Akbar’s passion project has expanded its reach to attract medical tourists from GCC, and Africa, and now aims to conquer Europe and parts of Asia, leveraging Dubai’s central location as a prime medical tourism hub.

Portuguese, born in Angola in 1968, Marcelo Nuno Gonçalves Pereira holds a degree in Economics from the University of Coimbra and a Master's degree in European Economics from ICADE, Madrid. He began his career in the financial sector (first in Banking and then in capital markets), but soon began to assume leadership roles and greater responsibility in companies in other sectors. Concurrently, Marcelo Pereira has taught at several universities. He taught in Economics, Management, and Auditing courses/programs, covering disciplines such as Strategic Planning, Management Control, Microeconomics, and Marketing at both undergraduate and Master’s levels. With extensive experience in both the private and public sectors, Marcelo has managed companies across diverse industries, including financial services (with roles as director in financial institutions and capital markets brokerage), water supply and sanitation sector, manufacturing, services, and Oil & Gas. His career has predominantly involved multinational corporations, though he has also had significant roles in many different sectors, including consultancy for various companies and government entities. Marcelo Pereira is a Senior Manager at the European healthcare group IDEALMED GHS and has been the CEO of Oman International Hospital (OIH) since early 2021, a year before its opening, assigned to this role by IDEALMED, the operator of OIH. Under his leadership, OIH, a private hospital classified as Band A+, has rapidly become the largest in its segment in Oman, surpassing established competitors with decades of operation. Despite its relatively short history, OIH has developed several centres of excellence, attracting patients from across the globe and transforming the local healthcare landscape, which previously relied heavily on treatment abroad.

A natural visionary Leader with unique Coaching and Transformational abilities with a phenomenal track record of challenging businesses turnaround. Having been in Pharma for more than 34 years, heading a mix of senior Commercial and General Management Leading roles over the last 25 years, the last 14 years, in particular, were strong career highlights. Between 2009 and 2018, filled the senior Executive Roles as a Regional President leading Pfizer's various business segments, Consumer Health, Nutrition, and Pharmaceuticals, and leading businesses ranging from $400M - $B 1.3 in regions like Europe, the Middle East, and Africa. Currently the CEO of Jamjoom Pharma, one of the leading regional players in the Middle East.

Dr. Abdullah M. Assiri is a highly accomplished research executive and scientist with a distinguished career in comparative medicine, reproductive biology, and translational research. He obtained his Ph.D. from Washington State University (WSU), where he completed his post-doctoral fellowship in School of Molecular Biosciences at WSU. Currently serving as the Deputy Executive Director of the Research Centre at King Faisal Specialist Hospital & Research Centre (KFSHRC), Dr. Assiri has been a driving force behind numerous groundbreaking initiatives. He has been instrumental in establishing the Transplant Research and Innovation Department, which has become a cornerstone for cutting-edge research in organ transplantation research and innovation. Under his leadership, KFSHRC achieved a significant milestone by becoming the first institution in Saudi Arabia to produce a genetically altered mouse model using CRISPR-Cas9 technology addressing human infertility issue. Dr. Assiri’s expertise extends beyond the laboratory. He is a crucial figure in several national and international committees, including as ex-Vice Chair of the National Committee of Bioethics at King Abdulaziz City for Science and Technology. His contributions to science have been recognized with numerous accolades, and he has co-founded multiple research groups focused on advancing knowledge in male and female infertility, fertility preservation, and surgical innovation. In addition to his research and administrative duties, Dr. Assiri is a dedicated educator, holding an adjunct faculty position at Alfaisal University, where he co-founded the Clinical Embryology and Reproductive Biology Master’s program. His commitment to education and mentorship has influenced the careers of many young scientists and medical professionals. A visionary leader and a passionate advocate for scientific excellence, Dr. Abdullah M. Assiri remains dedicated to advancing healthcare through research and innovation, contributing to the global scientific community while shaping the future of medical research in Saudi Arabia.

Ramzi is a distinguished entrepreneur, technologist, and executive with more than two decades of experience in crafting and implementing cutting-edge solutions for clients. Armed with a PhD in AI, he is currently the Director of Research Development and Engagement at MBZUAI, where he plays a pivotal role in boosting research collaboration, fostering entrepreneurship, and facilitating knowledge exchange in AI and interdisciplinary fields, both locally and internationally. Renowned for his extraordinary leadership skills and his expertise for establishing strategic alliances, Ramzi is committed to propelling research, innovation, and sustainable development within the university's vibrant ecosystem. His impressive stint as the CTO for IBM in France and subsequently for the Middle East and Africa region is marked by his transformative leadership, notably leading to the creation of a landmark research collaboration with MBZUAI. Serving on the board of the Computer Science department at UTC and actively engaging in various professional networks and NGOs, Ramzi's dedication to sustainability and innovation is commendable.

Dr. Nadia Cheaib is Doctor in Pharmacy and medical sciences from France. She started by founding in 2002, ClinServ, the pioneer comprehensive CRO of the MEA, after 7 years as heads departments experience in international CRO in France. Then ClinServ became the first sister of the Holding family ClinGroup, after creating Clinpharm for health logistics solutions, Clinfo1T for health projects management & post marketing solutions, ClinAcademy for professional trainings & Diplomas, QSI for quality & digital innovation & Franchising solutions, and many spin off since. The group, covering today over 60 countries in terms of activities and operations, with over 500 international sustainable customers, is also pioneer in social responsibility in the Arab world, through its foundation Hope MCF named after Dr. Cheaib father legacy. Hope MCF is partner of the league of Arab states and union of Arab chambers of commerce on key initiatives taken by the trio with annual sustainable programs, in terms of social responsibility and women empowerment especially women health.

Ismail's distinguished career spans over 25 years in senior management roles, with a decade dedicated to strategic planning, operational efficiency, business development, and manufacturing in the pharmaceutical sector across diverse regions and therapeutic domains. Currently serving as the CEO of Tabuk Pharmaceuticals, Ismail previously held the position of Chief Executive Officer (CEO) of the Pharma sector within the Saudi Chemical Holding Group (SCCH). His leadership extends to roles as chairman and board director of the Care Supply Chain, a joint venture with a prestigious German company. Prior to his current roles, Ismail made significant contributions as the Country President for the Gulf Cooperation Council & Pakistan cluster at AstraZeneca, and as the Country Manager for Saudi Arabia at GlaxoSmithKline (GSK). Ismail's impact on the Saudi Pharmaceutical industry is evident through his leadership in the private sector sub-committee at the National Committee for Pharmaceutical Industries (NCPI) and as Vice Chairman of the Research-Based Pharmaceutical Companies (RPCC). He has played a pivotal role in advocacy projects and shaping health policy issues in Saudi Arabia.

Dr. Asma Al Halaseh has over 18 years of extensive experience in leading, planning, and scaling healthcare operations, medical affairs, and healthcare services. She has successfully directed general and specialty, standalone and network hospitals and clinics, such as Medcare Group, Al Zahra Hospital, and the Healthcare Division of the Gulf Marketing Group. In her current role as CEO of Ambulatory Healthcare Services, part of the PureHealth network -the largest healthcare platform in the Middle East, Dr. Asma is leading a network of multi-specialty centers providing preventive and curative care for the community in Abu Dhabi Emirate. Dr. Asma holds a Bachelor of Medicine, Bachelor of Surgery Masters (M.B.B.S), and an MBA from the S. P. Jain School of Management.

Dr. Mohamed Mazen Batterjee is a business leader in the pharmaceutical industry. He is the managing director of Batterjee Pharma one of the region’s most prominent and fastest-growing Pharmaceutical companies with a presence in over 15 markets. Batterjee Pharma is also the approved CDMO for several multinational and regional companies. Additionally, Dr. Batterjee is the Co-Founder of AUMET, the leading B2B health platform in the region, active in five different countries and providing AI-Powered ERP for pharmacies that is integrated with a B2B marketplace.

Dr. Marwan Al Kaabi is the acting chief executive officer (CEO) at Sheikh Shakhbout Medical City (SSMC). With over 17 years of hands-on experience in successfully performing complex operations and leading large teams, Dr. Al Kaabi has earned a reputation as an expert in driving operational efficiency, improving customer care and enterprise risk management. Prior to joining SSMC, Dr. Al Kaabi played a pivotal role in safeguarding critical infrastructure and functions as PureHealth’s chief of critical infrastructure management and response. His role extended to developing and implementing incident and crisis management plans and establishing stringent security protocols and health and safety standards. Dr. Al Kaabi served as the chief operations officer (COO) at Abu Dhabi Health Services Company (SEHA), where his visionary leadership steered the organization through multiple strategic initiatives. Driven by a commitment to advancing healthcare delivery, Dr. Al Kaabi brings a wealth of experience, expertise and a proven track record of success to SSMC. Additionally, he is a member of the Advisory Board of the United Arab Emirates University. Dr. Al Kaabi is a Medical Doctor (M.D.) and holds a Master’s degree in Health Emergency Management from Boston University, United States, and executive certificate in managing healthcare delivery from Harvard Business School. His academic pursuits have equipped him with a comprehensive understanding of medical practice and healthcare management.

Dr. Georges Pascal Haber is the CEO of Cleveland Clinic Abu Dhabi, professor of surgery, and a renowned urologist specializing in robotics. He leads a team of over 5,600 caregivers, focusing on strategic growth, innovation, and excellence in high-acuity care, and aligning with Cleveland Clinic and M42’s joint mission to drive innovation and implement tech-enabled health solutions. Dr. Haber is a surgical innovator, having performed several firsts in scar-free kidney and prostate surgery, robotic kidney transplant, and robotic IVC thrombectomy. He has a strong commitment to medical research and education, having authored over 250 peer-reviewed scientific articles, served as a visiting professor in over a dozen countries, and led the largest and top-ranked urology training program in the US. Dr. Haber completed his executive education at Wharton and Harvard Business Schools; his clinical fellowship in robotic urologic surgery at Cleveland Clinic; and his Master of Science in Surgical Oncology, PhD in Biotechnology, and medical training in France.

Farah Hamdan is a seasoned business leader with more than 18 years of experience in the Healthcare industry with a profound knowledge in the Pharmaceutical and Medical device sectors. She has extensive experience in Leadership, Transformation and strategy roles within global organizations in different geographies. In her current role as General Manager spanning Middle East , North Africa and Turkey For Zimmer Biomet ; Farah is responsible for the regional growth through enhancing the footprint and investment across the area during this transformative period in Health care. Her Main Focus is partnering with hospitals and health authorities to help them benefit from Zimmer Biomet’s technology and data to improve efficiency and patient outcomes to alleviate pain and improve quality of life for people around the world

Arindam leads PureLab as its first CEO, who set up the organization structure and led the integration of the legacy business of PureHealth in the Northern Emirates by acquiring the biggest lab asset in Abu Dhabi, to create the largest lab network in the region. The business model comprises managing labs in multi-specialty hospitals, clinics, and primary healthcare centres, and handling large-scale national healthcare screening programs. He has played a pivotal role in shaping and establishing the PureLab brand, positioning us as an “Always Dependable” partner and paving the way for the future of PureLab. He has about three decades of business expertise in a range of executive positions. Throughout his professional career, Arindam has led companies and expanded portfolios in a variety of business verticals. His extensive experience includes key leadership roles across various facets of business management. His background encompasses CEO at Thyrocare Technologies Limited and SRL Diagnostics, India’s largest chain of branded labs. In addition, he has also served as Chief Marketing Officer at Sterlite Technologies Limited. and other significant roles across industry verticals.

Rizwan Tufail is the Group Chief Data Officer at PureHealth. He leads the group-wide data and analytics strategy and execution at Pure Health, helping the group leverage data to advance its longevity vision. He brings 30+ years of experience - across North America, Europe, Africa, and the Middle East - including 10 years leading Microsoft's work across Africa and 4+ years starting, growing, and eventually selling his own startup in the Silicon Valley. He holds master's degrees in management from Harvard and Chicago Booth and is also a PhD/ABD in economics from the University of Chicago.

Ahmad Abu Ghazaleh currently serves as the Chairman of United Cables Industries Company (UCIC), a Jordanian publicly traded company, a position he has held since 2013. Since 2003, he has served as the Vice Chairman and Chief Executive Officer of the International Wings Group including the Royal Jordanian Air Academy, Arab Wings, Queen Noor Technical College and Gulf Wings. He is also Founder and Executive Vice Chairman of Abdali Hospital in Amman, Jordan. Ahmad currently serves on several boards of directors of private and public organizations including, Fresh Del Monte Produce (NYSE: FDP), Queen Rania Foundation, Endeavor Jordan, the American Center for Oriental Research (ACOR), Jordan’s Investment Council and the Center for Strategic Studies Jordan University. He served as the Chairman of National Poultry Company (NPC), a publicly traded company from 2017 to 2019 and was a Board member of Banque Misr Liban from 2018 to 2020. He also previously served on the boards of directors of Arab Pharmaceutical Company and Modern Pharma both publicly traded companies that he helped merge and subsequently sell to Hikma Pharmaceuticals (HIK:Lon). Ahmad Abu Ghazaleh is the founder of the MMAG Foundation campus in Amman, a free art school, exhibition space and community center. He is an active member of several museum councils and advisory groups. * Recipient of the Atlantic Council's Rafic Hariri Business Entrepreneurship Award. * Forbes Middle East’s Top 100 Travel and Tourism Leaders 2023 and 2024.

Dr. Jaylan Ahmed is the esteemed CEO of the Baheya Foundation, a renowned non-profit organization in Egypt dedicated to providing free breast cancer screening, diagnosis, and treatment for underprivileged women. Her visionary leadership has propelled the foundation to offer comprehensive care to thousands of patients annually. Dr. Jaylan's passionate commitment to improving breast cancer outcomes for underprivileged women has established her as a respected figure in the global health community and a champion for women's health. Under her guidance, the Baheya Foundation has rapidly expanded, establishing multiple cuttingedge facilities equipped with advanced diagnostic technologies and treatment capabilities. Notably, the centers also offer ancillary support services such as counseling and rehabilitation, ensuring holistic patient care and emphasizing Dr. Jaylan's dedication to enhancing the well-being of those in need.

Dr Iman Fouad Itani is a distinguished Medical practitioner in non-surgical aesthetic medicine, now leading Lueur Aesthetic Clinic in Dubai. With extensive experience across various medical centers and advanced expertise in managing aesthetic complications and ultrasound-guided treatments, Dr. Itani is renowned for her commitment to safety and professional ethics. Her profound impact on the field, combined with her dedication to enhancing patients' beauty and well-being, has solidified her reputation as a trusted and highly skilled practitioner in aesthetic medicine

Dr. Mohammed Naji is an Orthodontist specialized in Laser Dentistry and the Executive Director of Liberty Medical Group which was established in the UAE since 1998. He also holds a degree in Healthcare Management & Administration and achieved a milestone by leading the renowned Liberty Dental Clinic to become the first internationally accredited dental practice in the MENA region by the ISQua approved ACHS accreditation. Dr. Naji and his organization are active members of Dubai Health Experience (DXH) the prestigious brand conceived by the Dubai Health Authority (DHA) to strengthen and promote the medical tourism strategies.

Junaid Khan is the Chief Executive Officer of PureCS, a leading health-tech company. Boasting over 22 years of experience, he brings a distinguished legacy in healthcare and innovative technology to PureCS. In this role, Junaid had the opportunity to develop the foundations of the organisation, playing a pivotal role in defining core values, operational strategies, and product offerings for the company. His passion for envisioning new opportunities and business lines is evident in his track record of transforming concepts into business realities. As the CEO of PureCS and CTO for PureHealth Group, Junaid has defined and executed the group’s technological vision, steering the organization toward new heights. He is a leader who not only adapts to change but thrives in shaping the future. Prior to joining PureCS, Junaid held the role of Services Sales Director for NCR Corporation, where he honed his leadership expertise in the payments and managed services domain. Junaid’s expertise spans critical areas such as healthcare, cloud, cybersecurity, ERP, electronic payments, and large-scale transformation projects. The success of these endeavors is a testament to his ability to lead and collaborate with exceptional teams, fostering lasting relationships in the process. Junaid holds an MBA from the Institute of Business Administration, and he has won numerous awards in his professional career.

Dr. Ram Kumar Narain, Chief Administrative Officer, brings a wealth of expertise to his role at SSMC, both in terms of his medical expertise and in his primary role of strategic planning and administrative operations. Dr. Narain oversees the operational and clinical support services at the facility alongside the development and activation of the annual operating plan with SSMC’s long-term strategy in mind. Dr. Narain’s academic journey includes Cardiac Surgery training at the University Hospital of Wales, Cardiff, UK, and Toronto General Hospital, University of Toronto, Canada. Complementing his clinical acumen, he pursued Management Training at the Indian Institute of Management and Singapore Management University. He also has affiliations with the Indian Institute of Healthcare Management & Research University as Vice Chairman of the Academic Advisory Council and Visiting Faculty Member. After eight years abroad, Dr. Narain returned to India in 1999 as the CEO and Medical Director of a 110-bed Heart Institute. Subsequently, he joined the Reliance Group in 2006 to lead a team establishing the Kokilaben Hospital, an 875-bed quaternary facility in Mumbai. Holding the position of Executive Director for more than 14 years, he played a pivotal role in design, planning, project management, commissioning, operations, clinical governance and strategic planning for the hospital. Dr. Narain went on to take up the position of Chief Operating Officer at the Emirates Hospitals Group, Dubai, from 2019 to 2023, overseeing a vast network of hospitals, medical centers and pharmacies across multiple emirates, in the UAE. Prior to joining SSMC, he served as the Chief Medical Officer at The Medical Office, PureHealth.

Abdallah Alhouti is a seasoned professional with Sufficient expertise in Acute Care and Trauma science, modern health care management, and leadership. With a career dedicated to advancing patient care and optimizing health systems, Abdallah has distinguished himself as a leader and innovator in the healthcare field. Abdallah’s background in Acute Care and Trauma Science equips him with a profound understanding of the complexities involved in managing critical and emergency situations. His hands-on experience in high-stakes environments has honed his ability to make swift, informed decisions that directly impact patient outcomes and enhance overall care quality. In the realm of modern health care management, Abdallah has demonstrated a keen aptitude for integrating contemporary practices with traditional models to improve efficiency and effectiveness. His approach to health care management is characterized by a commitment to evidence-based practices and a focus on patient-centred care. Abdallah’s leadership in this area has led to the successful implementation of innovative strategies that drive organizational excellence and adapt to the evolving demands of the healthcare landscape. Abdallah’s leadership skills are further exemplified by his ability to inspire and guide multidisciplinary teams. He is known for his strategic vision, collaborative approach, and dedication to fostering a culture of continuous improvement. His leadership philosophy emphasizes the importance of empowering team members, promoting professional development, and ensuring that all stakeholders are aligned with the overarching goals of the organization. With a track record of achievements in both clinical and administrative roles, Abdallah Alhouti continues to be a driving force in advancing healthcare practices and leadership. His commitment to excellence and passion for improving patient care underscore his contributions to the field and his ongoing influence on the future of healthcare.

Dr. Zain Al Yafei is the Chief Executive Officer of SAKINA. He is dedicated to providing accessible, comprehensive, and empathetic mental health care. With over 18 years of experience, he previously served as the Chief Medical Officer at Purelab and as the Director of Pharmacy and Allied Health at SEHA. Dr. Zain is accredited by the American Board of Medical Laboratory Immunology and holds a PhD in Immunology from the University of Bristol, UK.

Sally is a senior presenter and keynote speaker who has interviewed many of the world’s most influential change-makers across every field over the last two decades. She regularly speaks on transformation, leadership, communication, women's empowerment, and intercultural dialogue. From Prince Khaled bin Alwaleed bin Talal to Nobel Laureates like Kailash Satyarthi, Hollywood superstars like Steve Harvey, Olympic medallists like Ibtihaj Muhammad, visionaries like Dr Jane Goodall, top coaches and authors like Robin Sharma and Jay Shetty, amongst many others, Sally has a gift for telling the stories of those who have made a global impact, revealing deeper insights that others miss. As an Arab-Australian, Sally is passionate about powerful stories that explore diverse narratives and are part of conversations driving change worldwide.

Ramia is a Senior Producer and Presenter at Forbes Middle East, as well as a Moderator with a long history of hosting a variety of public and private sector events. At Forbes, Ramia hosts the Daily Brief, an online twice daily show focusing on breaking business news. She also conducts interviews with international business and world leaders. From its launch in 2007 until 2021, Ramia led the Emirates News broadcast on Dubai One TV as the Presenter and News Bulletin Editor. Previous to her role at Emirates News, from 2002 to 2007, Ramia presented and produced the program Business Arabia, which aired internationally on CNBC. Ramia has interviewed several world leaders including General Pervez Musharraf, President of Pakistan, Mohammed Khatami, President of Iran, Gerhard Schroeder, Chancellor of Germany and Jimmy Carter, US President. She is a moderator at major events including the World Government Summit in Dubai, the Middle East Investment Forum, and the Forbes 30/50 Summit, to name a few. Ramia holds a MA in Global Diplomacy-International Relations from the University of London, SOAS, as well as a BA in Communications from the University of Winnipeg and an associate degree in Journalism from Red River College.

As the Women Editor and Researcher at Forbes Middle East, Layan oversees a few lists and rankings and helps in creating the rest. She also writes for the cover of the printed monthly magazine of Forbes Middle East and hosts and produces The Under 30 Chit-Chat, a podcast dedicated to highlighting our 30 Under 30 listers who are shaping the future of the region. Layan holds a bachelor’s degree in journalism from The American University of Sharjah and has interviewed top decision-makers and some of the most important business leaders of the MENA region for print and video. She has also moderated and hosted several events across the region.

Manal Rostom is Egypt's most prominent marathoner & female mountaineer. In 2020 she was listed as one of “Africa’s top 50 most powerful women” by Forbes. Manal also became the Global face of the Nike Pro Hijab in March 2017 and starred in Nike’s Dream Crazier Campaign in 2019. She recently made history as first Egyptian woman to climb Mount Everest and finish the 6 World Marathon Majors. Manal embodies the ethos of ‘inspiration with impact’ having used sports, her ideas, passion and positivity to change perceptions and lives around the world. She is the founder of the world’s largest hijab wearing community on Facebook : Surviving Hijab.